1. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy : case report and review. Clin Infect Dis. 1994; 19:1092–1099. PMID:
7888539.
Article
2. Álvarez-Salgado JA, Ruiz-Ginés JA, Fuentes-Ventura CD, Gonzales-Sejas AG, Belinchón de Diego JM, González-Llanos Fernández de Mesa F, et al. [Intracranial tuberculoma simulating a malignant tumor : case report and literature review]. Neurocirugia (Astur). 2011; 22:600–604. PMID:
22167292.
3. Be NA, Kim KS, Bishai WR, Jain SK. Pathogenesis of central nervous system tuberculosis. Curr Mol Med. 2009; 9:94–99. PMID:
19275620.
Article
4. Burman WJ, Jones BE. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med. 2001; 164:7–12. PMID:
11435232.
Article
5. Chambers ST, Hendrickse WA, Record C, Rudge P, Smith H. Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet. 1984; 2:181–184. PMID:
6146749.
Article
6. Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, et al. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002; 21:803–809. PMID:
12461590.
Article
7. Cheng VC, Yam WC, Woo PC, Lau SK, Hung IF, Wong SP, et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2003; 22:597–602. PMID:
14508660.
Article
8. Coffey KC, Carroll VG, Steele RW. Ring-enhancing central nervous system lesions. Clin Pediatr (Phila). 2012; 51:1115–1118. PMID:
22669978.
Article
9. Das A, Das SK, Mandal A, Halder AK. Cerebral tuberculoma as a manifestation of paradoxical reaction in patients with pulmonary and extrapulmonary tuberculosis. J Neurosci Rural Pract. 2012; 3:350–354. PMID:
23188994.
Article
10. DeLance AR, Safaee M, Oh MC, Clark AJ, Kaur G, Sun MZ, et al. Tuberculoma of the central nervous system. J Clin Neurosci. 2013; 20:1333–1341. PMID:
23768968.
Article
11. Garcia-Monco JC. Central nervous system tuberculosis. Neurol Clin. 1999; 17:737–759. PMID:
10517926.
Article
12. Gupta RK, Kumar S. Central nervous system tuberculosis. Neuroimaging Clin N Am. 2011; 21:795–814. vii–viii. PMID:
22032500.
Article
13. Kumar R. Atypical response to chemotherapy in neurotuberculosis. Br J Neurosurg. 1998; 12:344–348. PMID:
10070428.
Article
14. Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins Basic Pathology, Eighth Edition. ed 8. Philadelphia, PA: Saunders/Elsevier;2007. p. 516–522.
15. Malone JL, Paparello S, Rickman LS, Wagner KF, Monahan B, Oldfield EC. Intracranial tuberculoma developing during therapy for tuberculous meningitis. West J Med. 1990; 152:188–190. PMID:
2305578.
16. Radmanesh F, Nejat F, El Khashab M. Cerebral infarction as the first presentation of tuberculosis in an infant : a case report. J Microbiol Immunol Infect. 2010; 43:249–252. PMID:
21291854.
Article
17. Smith H. Paradoxical responses during the chemotherapy of tuberculosis. J Infect. 1987; 15:1–3. PMID:
3668262.
Article
18. Trivedi R, Saksena S, Gupta RK. Magnetic resonance imaging in central nervous system tuberculosis. Indian J Radiol Imaging. 2009; 19:256–265. PMID:
19881100.
Article